Taille et prévisions du marché des injections intra-articulaires pour les infiltrations ostéoarticulaires en Europe (2021-2031), analyse des tendances et des opportunités de croissance : par type [collagène de type 1 (polymérisé, hydrolysé et atélocollagène) et acide hyaluronique], utilisateur final (hôpitaux, cliniques orthopédiques et autres) et pays
Les injections intra-articulaires pour l\'arthrose sont une procédure médicale au cours de laquelle un médicament est injecté directement dans une articulation touchée par l\'arthrose. Cette approche vise à réduire la douleur et à améliorer la fonction articulaire. La sensibilisation croissante des professionnels de la santé et des patients aux avantages de ces injections, combinée à l\'augmentation des investissements dans les infrastructures de santé et l\'innovation, facilite un accès accru à ces traitements. La prévalence croissante de l\'arthrose et les progrès des techniques d\'injection sont des facteurs notables contribuant à l\'expansion de la taille du marché européen des injections intra-articulaires pour les infiltrations ostéoarticulaires. Cependant, les effets secondaires associés aux injections intra-articulaires entravent la croissance du marché européen des injections intra-articulaires pour les infiltrations ostéoarticulaires.
Les injections intra-articulaires font partie des domaines innovants et émergents du traitement des infiltrations ostéoarticulaires. Les fabricants participent à divers essais cliniques pour garantir la sécurité, l\'efficacité et la fiabilité des médicaments innovants. Par exemple, en mai 2024, la société suédoise Synartro a lancé une levée de fonds comprise entre 3,73 et 7,36 millions de dollars américains pour mener une étude clinique du candidat médicament SYN321 contre l\'arthrose. Elle est en phase finale pour obtenir une subvention de l\'UE de 2,78 millions de dollars américains. En outre, en avril 2023, la société a reçu l\'approbation de l\'Agence suédoise des produits médicaux et de l\'Autorité suédoise d\'examen éthique pour démarrer la première étude clinique de phase 1/2a sur l\'homme du candidat médicament expérimental SYN321. D\'autres acteurs du marché dans les régions mènent également des essais cliniques pour les injections intra-articulaires, qui peuvent conduire au développement de produits innovants. Par exemple, en août 2022, Grünenthal, une société allemande, a recruté le premier patient dans son programme clinique mondial de phase III pour la résinifératoxine (RTX). Grünenthal a mené trois essais dans environ 200 sites en Europe, aux États-Unis, en Amérique latine, en Afrique du Sud et au Japon pour étudier la sécurité et l\'efficacité des injections intra-articulaires de RTX chez les adultes. Les résultats observés dans les essais se concentrent principalement sur une amélioration de la fonction physique et du score de douleur dans l\'indice d\'arthrose des universités Western Ontario et McMaster (WOMAC) de la ligne de base à 52 semaines. Une fois terminé, le programme de phase III devrait donner une autorisation de mise sur le marché du RTX en Europe, aux États-Unis et au Japon. La société a l\'intention de soumettre une nouvelle demande de médicament en 2024, indiquant l\'entrée potentielle du RTX sur le marché en 2025. Par conséquent, le nombre croissant d\'essais cliniques devrait favoriser le développement de produits innovants dans la région, ce qui, à son tour, contribuera à la croissance du marché européen des injections intra-articulaires pour les infiltrations ostéoarticulaires dans les années à venir.
Informations basées sur le type
Sur la base du type, le marché européen des injections intra-articulaires pour infiltrations ostéoarticulaires est segmenté en collagène de type 1 et acide hyaluronique. Le segment de l\'acide hyaluronique détenait la plus grande part de marché européenne des injections intra-articulaires pour infiltrations ostéoarticulaires en 2023. Les injections d\'acide hyaluronique sont utilisées pour traiter les douleurs au genou chez les patients qui ne répondaient pas aux autres options de traitement. Les progrès récents dans la thérapie par injection d\'acide hyaluronique ont considérablement élargi la trajectoire de croissance. Une concentration solide sur le développement et l\'introduction de nouveaux produits sur le marché devrait soutenir la croissance du segment, contribuant ainsi à la croissance du marché.
Les Centers for Disease Control and Prevention, l\'Organisation mondiale de la santé et le National Center for Biotechnology Information font partie des sources primaires et secondaires mentionnées lors de la préparation du rapport sur le marché européen des injections intra-articulaires pour infiltrations ostéoarticulaires.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Information on why collagen injections are better than HA injections
4.4 Pricing Analysis
5. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Key Market Dynamics
5.1 Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Rising Prevalence of Osteoarthritis
5.2.2 Advancements in Injection Techniques
5.3 Market Restraints
5.3.1 Side Effects Associated with Intra-Articular Injections
5.4 Market Opportunities
5.4.1 Strategic Initiatives in Intra-Articular Injection for Osteoarticular Infiltrations
5.5 Future Trends
5.5.1 Increasing Number of Clinical Trials
5.6 Impact of Drivers and Restraints:
6. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Analysis
6.1 Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Revenue (US$ Million), 2021–2031
6.2 Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Forecast and Analysis
7. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Analysis – by Type
7.1 Type 1 Collagen
7.1.1 Overview
7.1.2 Type 1 Collagen: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Hyaluronic Acid
7.2.1 Overview
7.2.2 Hyaluronic Acid: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
8. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Analysis – by End User
8.1 Hospitals
8.1.1 Overview
8.1.2 Hospitals: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
8.2 Orthopedic Clinics
8.2.1 Overview
8.2.2 Orthopedic Clinics: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Others
8.3.1 Overview
8.3.2 Others: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
9. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Country Analysis
9.1 Europe
9.1.1 Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Countries
9.1.2 Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Revenue and Forecast and Analysis – by Country
9.1.2.1 Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Revenue and Forecast and Analysis – by Country
9.1.2.2 Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
9.1.2.2.1 Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type
9.1.2.2.2 Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen
9.1.2.2.3 Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User
9.1.2.3 United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
9.1.2.3.1 United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type
9.1.2.3.2 United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen
9.1.2.3.3 United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User
9.1.2.4 France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
9.1.2.4.1 France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type
9.1.2.4.2 France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen
9.1.2.4.3 France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User
9.1.2.5 Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
9.1.2.5.1 Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type
9.1.2.5.2 Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen
9.1.2.5.3 Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User
9.1.2.6 Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
9.1.2.6.1 Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type
9.1.2.6.2 Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen
9.1.2.6.3 Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User
9.1.2.7 Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
9.1.2.7.1 Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type
9.1.2.7.2 Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen
9.1.2.7.3 Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User
9.1.2.8 Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
9.1.2.8.1 Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type
9.1.2.8.2 Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen
9.1.2.8.3 Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User
10. Industry Landscape
10.1 Overview
10.2 Growth Strategies in Intra-Articular Injection For Osteoarticular Infiltrations Market
10.3 Organic Growth Strategies
10.3.1 Overview
10.4 Inorganic Growth Strategies
10.4.1 Overview
11. Company Profiles
11.1 Bioventus Inc
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 SEIKAGAKU CORPORATION
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Maxigen Biotech Inc.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 ?stem Medical Inc.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Sanofi SA
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Ferring Pharmaceuticals
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Fidia Pharma USA Inc.
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Biotech Healthcare Group
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Bioteck S.p.A.
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 I+MED
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
List of Tables
Table 1. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Segmentation
Table 2. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
Table 3. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 4. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type 1 Collagen
Table 5. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 6. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Country
Table 7. Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 8. Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type 1 Collagen
Table 9. Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 10. United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 11. United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type 1 Collagen
Table 12. United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 13. France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 14. France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type 1 Collagen
Table 15. France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 16. Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 17. Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type 1 Collagen
Table 18. Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 19. Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 20. Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type 1 Collagen
Table 21. Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 22. Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 23. Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type 1 Collagen
Table 24. Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 25. Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 26. Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type 1 Collagen
Table 27. Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 28. Recent Organic Growth Strategies in Intra-Articular Injection For Osteoarticular Infiltrations Market
Table 29. Recent Inorganic Growth Strategies in the Intra-Articular Injection For Osteoarticular Infiltrations Market
Table 30. Glossary of Terms, Europe Intra-Articular Injection For Osteoarticular Infiltrations Market
List of Figures
Figure 1. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Segmentation, by Country
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Revenue (US$ Million), 2021–2031
Figure 5. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Share (%) – by Type, 2023 and 2031
Figure 6. Type 1 Collagen: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
Figure 7. Hyaluronic Acid: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Share (%) – by End User, 2023 and 2031
Figure 9. Hospitals: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
Figure 10. Orthopedic Clinics: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
Figure 11. Others: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
Figure 12. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Key Countries, 2023 and 2031 (%)
Figure 13. Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
Figure 14. United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
Figure 15. France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
Figure 16. Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
Figure 17. Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
Figure 18. Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
Figure 19. Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
Figure 20. Growth Strategies in Intra-Articular Injection For Osteoarticular Infiltrations Market
- Bioventus Inc.
- SEIKAGAKU CORPORATION
- Maxigen Biotech Inc.
- ?stem Medical Inc.
- Sanofi SA
- Ferring Pharmaceuticals
- Fidia Pharma USA Inc.
- Biotech Healthcare Group
- Bioteck S.p.A.
- I+MED.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe intra-articular injection for osteoarticular infiltrations market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Europe intra-articular injection for osteoarticular infiltrations market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.